Publications by authors named "Jane Reese"

Claim this Profile
T
Treatment of non-Hodgkin lymphoma with point-of-care manufactured CAR T cells: a dual institution, phase 1 trial.
Armin Ghobadi, Paolo F Caimi, Jane S Reese, Krishna Goparaju, Martina di Trani

EClinicalMedicine· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401.
David J Chung, Nina Shah, Juan Wu, Brent Logan, Lina Bisharat, Jane Reese

Clin Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment effect of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of fistulizing Crohn's disease are durable at 12 months.
Amy L Lightner, Ana Otero Pineiro, Jane Reese, Justin Ream, Douglas Nachand

Surgery· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase IB/IIA study of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn's disease.
Amy L Lightner, Jane S Reese, Justin Ream, Douglas Nachand, Neda Dadgar

Surgery· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease.
Amy L Lightner, Ana Otero-Pineiro, Jane Reese, Justin Ream, Douglas Nachand

Inflamm Bowel Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401.
David J Chung, Nina Shah, Juan Wu, Brent Logan, Lina Bisharat, Jane Reese

Clin Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase IB/IIA Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease.
Amy L Lightner, Jane Reese, Justin Ream, Douglas Nachand, Xue Jia

Dis Colon Rectum· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study assessing the safety and tolerability of allogeneic mesenchymal stem cell infusion in adults with cystic fibrosis.
Erica A Roesch, Tracey L Bonfield, Hillard M Lazarus, Jane Reese, Kathleen Hilliard

J Cyst Fibros· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase IB/IIA Study of Allogeneic, Bone Marrow-derived, Mesenchymal Stem Cells for the Treatment of Refractory Ileal-anal Anastomosis and Peripouch Fistulas in the Setting of Crohn's Disease of the Pouch.
Amy L Lightner, Jane Reese, Justin Ream, Douglas Nachand, Xue Jia

J Crohns Colitis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo killing of primary HIV-infected cells by peripheral-injected early memory-enriched anti-HIV duoCAR T cells.
Kim Anthony-Gonda, Alex Ray, Hang Su, Yuge Wang, Ying Xiong, Jane S Reese

JCI Insight· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential Single-Cell Transcriptional and Protein Marker Profiling Reveals TIGIT as a Marker of CD19 CAR-T Cell Dysfunction in Patients with Non-Hodgkin Lymphoma.
Zachary Jackson, Changjin Hong, Robert Schauner, Boro Dropulic, Paolo F Caimi, Jane S Reese

Cancer Discov· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma.
Zachary Jackson, Anne Roe, Ashish Arunkumar Sharma, Filipa Blasco Tavares Pereira Lopes, Aarthi Talla, Jane S Reese

Front Immunol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of lenalidomide on collected hematopoietic myeloid and erythroid progenitors: peripheral stem cell collection may not be affected.
Talib Dosani, Fahrettin Covut, Raisa Pinto, Byung-Gyu Kim, Naveed Ali, Jane Reese

Leuk Lymphoma· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid-Dependent Mechanism.
Ayal Rozenberg, Ayman Rezk, Marie-Noëlle Boivin, Peter J Darlington, Mukanthu Nyirenda, Jane S Reese

Stem Cells Transl Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-osseous Co-transplantation of CD34-selected Umbilical Cord Blood and Mesenchymal Stromal Cells.
Leland Metheny, Saada Eid, Karen Lingas, Jane Reese, Howard Meyerson

Hematol Med Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment.
Morgan T Sutton, David Fletcher, Santosh K Ghosh, Aaron Weinberg, Rolf van Heeckeren, Jane Reese

Stem Cells Int· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MGMT enrichment and second gene co-expression in hematopoietic progenitor cells using separate or dual-gene lentiviral vectors.
Justin C Roth, Michael O Alberti, Mourad Ismail, Karen T Lingas, Jane S Reese

Virus Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cotransduction with MGMT and Ubiquitous or Erythroid-Specific GFP Lentiviruses Allows Enrichment of Dual-Positive Hematopoietic Progenitor Cells In Vivo.
Justin C Roth, Mourad Ismail, Jane S Reese, Karen T Lingas, Giuliana Ferrari

ISRN Hematol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging therapeutic approaches for multipotent mesenchymal stromal cells.
Paolo F Caimi, Jane Reese, Zhenghong Lee, Hillard M Lazarus

Curr Opin Hematol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow-derived cells exhibiting lung epithelial cell characteristics are enriched in vivo using methylguanine DNA methyltransferase-mediated drug resistance.
Jane S Reese, Justin C Roth, Stanton L Gerson

Stem Cells· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo selection of MGMT(P140K) lentivirus-transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioning.
Steven P Zielske, Jane S Reese, Karen T Lingas, Jon R Donze, Stanton L Gerson

J Clin Invest· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repopulating defect of mismatch repair-deficient hematopoietic stem cells.
Jane S Reese, Lili Liu, Stanton L Gerson

Blood· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug selection of mutant methylguanine methyltransferase from different oncoretroviral backbones results in multilineage hematopoietic transgene expression in primary and secondary recipients.
Brian M Davis, Jane S Reese, Karen Lingas, Stanton L Gerson

J Hematother Stem Cell Res· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablation is not required to select and maintain expression of the drug-resistance gene, mutant MGMT, in primary and secondary recipients.
Janice E Bowman, Jane S Reese, Karen T Lingas, Stanton L Gerson

Mol Ther· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis